SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer

SPARC/osteonectin expression is reportedly altered in various malignancies. However, little is known regarding to the prognostic value of SPARC in triple-negative breast cancer (TNBC) patients. In this study, immunohistochemistry and immunoreactive scores (IRSs) were used to evaluate SPARC protein e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Anjie, Yuan, Peng, Du, Feng, Hong, Ruoxi, Ding, Xiaoyan, Shi, Xiuqing, Fan, Ying, Wang, Jiayu, Luo, Yang, Ma, Fei, Zhang, Pin, Li, Qing, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363535/
https://www.ncbi.nlm.nih.gov/pubmed/27421134
http://dx.doi.org/10.18632/oncotarget.10532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363535/
https://www.ncbi.nlm.nih.gov/pubmed/27421134
http://dx.doi.org/10.18632/oncotarget.10532

Ejemplares similares